Henning Walczak

25PUBLICATIONS
210CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunityMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 28, 2026
HERC4-mediated ubiquitination licenses RIPK1 to initiate TNF-induced cell death.

|Sep 15, 2026
FasL-mediated death of activated intratumoral T cells drives secondary resistance to cancer immunotherapy.

|Aug 27, 2026
A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.

|Mar 06, 2026
Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS-STING and Toll-like receptors 3 and 4.

Alexis Betrancourt, M Talha Cinko, Ana Beatriz Varanda

|Nov 10, 2025
Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis.

Sebastian J Theobald, Kilian Dahm, Dinah Lange

|Sep 17, 2025
Linear ubiquitination prevents lipodystrophy and obesity-associated metabolic syndrome.

Ximena Hildebrandt, Önay Veli, Armel Hyoubi

Pageof 5

Frequent Collaborators

5 joint publications

Nieves Peltzer

4 joint publications

Diego de Miguel

4 joint publications

Jan Rybniker

3 joint publications

Alexander Simonis